SIGVOTATUG VEDOTIN
UNII QX0ONY0O9T

Substance Identification & Data

This profile provides standardized clinical and technical data for Sigvotatug Vedotin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) QX0ONY0O9T.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2764774-91-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

QX0ONY0O9T

CAS Registry Number

2764774-91-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

SIGVOTATUG VEDOTIN

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C203047

National Cancer Institute reference terminology for clinical and research data.

INN ID

12757

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

MN-202

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Sigvotatug Vedotin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

SIGVOTATUG VEDOTIN

Common Names & Synonyms

IMMUNOGLOBULIN G1-KAPPA, ANTI-(HOMO SAPIENS ITGB6 (INTEGRIN SUBUNIT BETA 6)), HUMANIZED MONOCLONAL ANTIBODY, CONJUGATED ON AN AVERAGE OF 4 CYSTEINYL RESIDUES VIA A CLEAVABLE LINKER TO MONOMETHYLAURISTATIN E (MMAE)

SIGVOTATUG VEDOTIN [INN]

SIGVOTATUG VEDOTIN [USAN]

SIGVOTATUG VEDOTIN [WHO-DD]

Systematic Nomenclature

IMMUNOGLOBULIN G1, ANTI-(HUMAN INTEGRIN .BETA.6) (HUMAN-MUS MUSCULUS MONOCLONAL H2A2 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL H2A2 .KAPPA.-CHAIN, DIMER, REDUCED, TETRAKIS(THIOETHER) WITH N-(((4-((N-(6-(3-MERCAPTO-2,5-DIOXO-1-PYRROLIDINYL)-1-OXOHEXYL)-L-VALYL-N5-(AMINOCARBONYL)-L-ORNITHYL)AMINO)PHENYL)METHOXY)CARBONYL)-N-METHYL-L-VALYL-N-((1S,2R)-4-((2S)-2-((1R,2R)-3-(((1R,2S)-2-HYDROXY-1-METHYL-2-PHENYLETHYL)AMINO)-1-METHOXY-2-METHYL-3-OXOPROPYL)-1-PYRROLIDINYL)-2-METHOXY-1-((1S)-1-METHYLPROPYL)-4-OXOBUTYL)-N-METHYL-L-VALINAMIDE

SYS